Dilijeta Bajrami
FDA investigator
Appears on 1 document from 2015, mostly at sites in New York. Most often cites responsibilities of quality control unit (21 CFR 211.22(c)).
- 1
- Documents on file
- 9.0
- Observations per 483
- 2015
- First seen
- 2015
- Most recent
What they cite most
From 9 observations- 21 CFR 211.22(c)Responsibilities of quality control unit2
- 21 CFR 211.125(a)Labeling issuance1
- 21 CFR 211.142(b)Warehousing procedures1
- 21 CFR 211.160(b)General requirements1
- 21 CFR 211.188Batch production and control records1
- 21 CFR 211.198(b)(2)Complaint files1
Activity by year
2015: 1
Where
New York 1
Often inspects with
Is Dilijeta Bajrami coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2015-06-02 | 483 Allegiant HealthJun 2, 2015 · Deer Park, New York | Deer Park, New York | 9 |
About this profile
What does Dilijeta Bajrami inspect?
Dilijeta Bajrami appears on 1 document on file covering 1 site, mostly in New York.
What do they cite most often?
21 CFR 211.22(c) (responsibilities of quality control unit), followed by 21 CFR 211.125(a) and 21 CFR 211.142(b).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Dilijeta Bajrami is dated Jun 2, 2015.